{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:13:45Z","timestamp":1791249225807,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Experimental evidence indicates vitamin D may play an important role in breast cancer etiology but epidemiologic evidence to date is inconsistent. Vitamin D comes from dietary intake and sun exposure and plasma levels of 25-hydroxyvitamin D (25(OH)D) are considered the best measure of vitamin D status.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We conducted a prospective nested case-control study within the Nurses' Health Study II (NHSII). Plasma samples collected in 1996 to 1999 were assayed for 25(OH)D in 613 cases, diagnosed after blood collection and before 1 June 2007, and in 1,218 matched controls. Multivariate relative risks (RR) and 95% confidence intervals (CI) were calculated by conditional logistic regression, adjusting for several breast cancer risk factors.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>No significant association was observed between plasma 25(OH)D levels and breast cancer risk (top vs. bottom quartile multivariate RR = 1.20, 95% CI (0.88 to 1.63), <jats:italic>P<\/jats:italic>-value, test for trend = 0.32). Results were similar when season-specific quartile cut points were used. Results did not change when restricted to women who were premenopausal at blood collection or premenopausal at diagnosis. Results were similar between estrogen receptor (ER)+\/progesterone receptor (PR)+ and ER-\/PR- tumors (<jats:italic>P<\/jats:italic>-value, test for heterogeneity = 0.51). The association did not vary by age at blood collection or season of blood collection, but did vary when stratified by body mass index (<jats:italic>P<\/jats:italic>-value, test for heterogeneity = 0.01).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Circulating 25(OH)D levels were not significantly associated with breast cancer risk in this predominantly premenopausal population.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr2880","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T19:12:21Z","timestamp":1305227541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II"],"prefix":"10.1186","volume":"13","author":[{"given":"A Heather","family":"Eliassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Spiegelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"key":"2691_CR1","first-page":"147","volume-title":"Vitamin D: Molecular Biology, Physiology, and Clinical Applications","author":"R Ray","year":"1999","unstructured":"Ray R: Molecular recognition and structure-activity relations in vitamin D-binding protein and vitamin D receptor. Vitamin D: Molecular Biology, Physiology, and Clinical Applications. Edited by: Holick MF. 1999, Totowa, NJ: Humana Press, 147-162."},{"key":"2691_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-3-642-55580-0_17","volume":"164","author":"M Friedrich","year":"2003","unstructured":"Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W, Reichrath J: Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res. 2003, 164: 239-246.","journal-title":"Recent Results Cancer Res"},{"key":"2691_CR3","doi-asserted-by":"crossref","first-page":"2425S","DOI":"10.1093\/jn\/133.7.2425S","volume":"133","author":"J Welsh","year":"2003","unstructured":"Welsh J, Wietzke JA, Zinser GM, Byrne B, Smith K, Narvaez CJ: Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr. 2003, 133: 2425S-2433S.","journal-title":"J Nutr"},{"key":"2691_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/jcb.10342","volume":"88","author":"TC Chen","year":"2003","unstructured":"Chen TC, Wang L, Whitlatch LW, Flanagan JN, Holick MF: Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J Cell Biochem. 2003, 88: 315-322. 10.1002\/jcb.10342.","journal-title":"J Cell Biochem"},{"key":"2691_CR5","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/S0140-6736(00)04831-5","volume":"357","author":"V Tangpricha","year":"2001","unstructured":"Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF: 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001, 357: 1673-1674. 10.1016\/S0140-6736(00)04831-5.","journal-title":"Lancet"},{"key":"2691_CR6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ajcn\/79.3.362","volume":"79","author":"MF Holick","year":"2004","unstructured":"Holick MF: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004, 79: 362-371.","journal-title":"Am J Clin Nutr"},{"key":"2691_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJM198904133201506","volume":"320","author":"H Reichel","year":"1989","unstructured":"Reichel H, Koeffler HP, Norman AW: The role of the vitamin D endocrine system in health and disease. N Engl J Med. 1989, 320: 980-991. 10.1056\/NEJM198904133201506.","journal-title":"N Engl J Med"},{"key":"2691_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/BF02509538","volume":"58","author":"BW Hollis","year":"1996","unstructured":"Hollis BW: Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int. 1996, 58: 4-5.","journal-title":"Calcif Tissue Int"},{"key":"2691_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0960-0760(02)00277-7","volume":"83","author":"J Welsh","year":"2002","unstructured":"Welsh J, Wietzke JA, Zinser GM, Smyczek S, Romu S, Tribble E, Welsh JC, Byrne B, Narvaez CJ: Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol. 2002, 83: 85-92. 10.1016\/S0960-0760(02)00277-7.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2691_CR10","first-page":"1370","volume":"15","author":"SS Jensen","year":"2001","unstructured":"Jensen SS, Madsen MW, Lukas J, Binderup L, Bartek J: Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol. 2001, 15: 1370-1380. 10.1210\/me.15.8.1370.","journal-title":"Mol Endocrinol"},{"key":"2691_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0140-6736(89)91204-X","volume":"1","author":"KW Colston","year":"1989","unstructured":"Colston KW, Berger U, Coombes RC: Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 1989, 1: 188-191.","journal-title":"Lancet"},{"key":"2691_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1023\/A:1024962316691","volume":"80","author":"KW Colston","year":"2003","unstructured":"Colston KW, Pirianov G, Bramm E, Hamberg KJ, Binderup L: Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors. Breast Cancer Res Treat. 2003, 80: 303-311. 10.1023\/A:1024962316691.","journal-title":"Breast Cancer Res Treat"},{"key":"2691_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1023\/A:1006879213501","volume":"188","author":"E Nolan","year":"1998","unstructured":"Nolan E, Donepudi M, VanWeelden K, Flanagan L, Welsh J: Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells. Mol Cell Biochem. 1998, 188: 13-20. 10.1023\/A:1006879213501.","journal-title":"Mol Cell Biochem"},{"key":"2691_CR14","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1210\/endo.139.4.5892","volume":"139","author":"K VanWeelden","year":"1998","unstructured":"VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J: Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. Endocrinology. 1998, 139: 2102-2110. 10.1210\/en.139.4.2102.","journal-title":"Endocrinology"},{"key":"2691_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jsbmb.2010.02.009","volume":"121","author":"AV Krishnan","year":"2010","unstructured":"Krishnan AV, Swami S, Feldman D: Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol. 2010, 121: 343-348. 10.1016\/j.jsbmb.2010.02.009.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2691_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1210\/jcem-36-2-207","volume":"36","author":"JM Grodin","year":"1973","unstructured":"Grodin JM, Siiteri PK, MacDonald PC: Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973, 36: 207-214. 10.1210\/jcem-36-2-207.","journal-title":"J Clin Endocrinol Metab"},{"key":"2691_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcn\/45.1.277","volume":"45","author":"PK Siiteri","year":"1987","unstructured":"Siiteri PK: Adipose tissue as a source of hormones. Am J Clin Nutr. 1987, 45: 277-282.","journal-title":"Am J Clin Nutr"},{"key":"2691_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11154-007-9034-4","volume":"8","author":"RF Swaby","year":"2007","unstructured":"Swaby RF, Sharma CG, Jordan VC: SERMs for the treatment and prevention of breast cancer. Rev Endocr Metab Disord. 2007, 8: 229-239. 10.1007\/s11154-007-9034-4.","journal-title":"Rev Endocr Metab Disord"},{"key":"2691_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jsbmb.2005.04.023","volume":"95","author":"D de Ziegler","year":"2005","unstructured":"de Ziegler D, Mattenberger C, Luyet C, Romoscanu I, Irion NF, Bianchi-Demicheli F: Clinical use of aromatase inhibitors (AI) in premenopausal women. J Steroid Biochem Mol Biol. 2005, 95: 121-127. 10.1016\/j.jsbmb.2005.04.023.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2691_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/jnci\/djj101","volume":"98","author":"E Giovannucci","year":"2006","unstructured":"Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006, 98: 451-459. 10.1093\/jnci\/djj101.","journal-title":"J Natl Cancer Inst"},{"key":"2691_CR21","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1158\/1055-9965.EPI-04-0722","volume":"14","author":"ER Bertone-Johnson","year":"2005","unstructured":"Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE: Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1991-1997. 10.1158\/1055-9965.EPI-04-0722.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2691_CR22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1158\/1055-9965.EPI-07-2594","volume":"17","author":"DM Freedman","year":"2008","unstructured":"Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, Hollis BW, Graubard BI, Berg CD, Ziegler RG: Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2008, 17: 889-894. 10.1158\/1055-9965.EPI-07-2594.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2691_CR23","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/jnci\/djn360","volume":"100","author":"RT Chlebowski","year":"2008","unstructured":"Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA, Women's Health Initiative Investigators: Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008, 100: 1581-1591. 10.1093\/jnci\/djn360.","journal-title":"J Natl Cancer Inst"},{"key":"2691_CR24","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/bcr2356","volume":"11","author":"ML McCullough","year":"2009","unstructured":"McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, Gapstur SM, Thun MJ, Calle EE: Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res. 2009, 11: R64-10.1186\/bcr2356.","journal-title":"Breast Cancer Res"},{"key":"2691_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ejca.2009.11.019","volume":"46","author":"CB Agborsangaya","year":"2010","unstructured":"Agborsangaya CB, Surcel H-M, Toriola AT, Pukkala E, Parkkila S, Tuohimaa P, Lukanova A, Lehtinen M: Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study. Eur J Cancer. 2010, 46: 467-470. 10.1016\/j.ejca.2009.11.019.","journal-title":"Eur J Cancer"},{"key":"2691_CR26","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/ijc.25215","volume":"127","author":"M Almquist","year":"2010","unstructured":"Almquist M, Bondeson A-G, Bondeson L, Malm J, Manjer J: Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study. Int J Cancer. 2010, 127: 2159-2168. 10.1002\/ijc.25215.","journal-title":"Int J Cancer"},{"key":"2691_CR27","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1158\/1055-9965.EPI-10-0264","volume":"19","author":"P Engel","year":"2010","unstructured":"Engel P, Fagherazzi G, Boutten A, Dupr\u00e9 T, Mesrine S, Boutron-Ruault M-C, Clavel-Chapelon F: Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev. 2010, 19: 2341-2350. 10.1158\/1055-9965.EPI-10-0264.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2691_CR28","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-05-3369","volume":"66","author":"SS Tworoger","year":"2006","unstructured":"Tworoger SS, Sluss P, Hankinson SE: Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res. 2006, 66: 2476-2482. 10.1158\/0008-5472.CAN-05-3369.","journal-title":"Cancer Res"},{"key":"2691_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00401706.1983.10487848","volume":"25","author":"B Rosner","year":"1983","unstructured":"Rosner B: Percentage points for a generalized ESD many-outlier procedure. Technometrics. 1983, 25: 165-172. 10.2307\/1268549.","journal-title":"Technometrics"},{"key":"2691_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/sim.4780040313","volume":"4","author":"RJ Marshall","year":"1985","unstructured":"Marshall RJ, Chisholm EM: Hypothesis testing in the polychotomous logistic model with an application to detecting gastrointestinal cancer. Stat Med. 1985, 4: 337-344. 10.1002\/sim.4780040313.","journal-title":"Stat Med"},{"key":"2691_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/sim.4780080504","volume":"8","author":"S Durrleman","year":"1989","unstructured":"Durrleman S, Simon R: Flexible regression models with cubic splines. Stat Med. 1989, 8: 551-561. 10.1002\/sim.4780080504.","journal-title":"Stat Med"},{"key":"2691_CR32","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1002\/sim.2848","volume":"26","author":"US Govindarajulu","year":"2007","unstructured":"Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA: Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med. 2007, 26: 3735-3752. 10.1002\/sim.2848.","journal-title":"Stat Med"},{"key":"2691_CR33","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1158\/1055-9965.EPI-09-1318","volume":"19","author":"J Kotsopoulos","year":"2010","unstructured":"Kotsopoulos J, Tworoger SS, Campos H, Chung F-L, Clevenger CV, Franke AA, Mantzoros CS, Ricchiuti V, Willett WC, Hankinson SE, Eliassen AH: Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev. 2010, 19: 938-946. 10.1158\/1055-9965.EPI-09-1318.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2691_CR34","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/oxfordjournals.aje.a116453","volume":"136","author":"B Rosner","year":"1992","unstructured":"Rosner B, Spiegelman D, Willett WC: Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol. 1992, 136: 1400-1413.","journal-title":"Am J Epidemiol"},{"key":"2691_CR35","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/jnci\/djm038","volume":"99","author":"K Wu","year":"2007","unstructured":"Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL: A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst. 2007, 99: 1120-1129. 10.1093\/jnci\/djm038.","journal-title":"J Natl Cancer Inst"},{"key":"2691_CR36","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/jnci\/djn135","volume":"100","author":"SS Maruti","year":"2008","unstructured":"Maruti SS, Willett WC, Feskanich D, Rosner B, Colditz GA: A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst. 2008, 100: 728-737. 10.1093\/jnci\/djn135.","journal-title":"J Natl Cancer Inst"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr2880\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:38:24Z","timestamp":1728383904000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr2880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,11]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,6]]}},"alternative-id":["2691"],"URL":"https:\/\/doi.org\/10.1186\/bcr2880","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,11]]},"assertion":[{"value":"21 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R50"}}